Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Free Subscription

Articles published in J Cardiovasc Pharmacol

Retrieve available abstracts of 6 articles:
HTML format
Text format

Single Articles

    January 2019
  1. CHENG W, Jia X, Li J, Cheng W, et al
    Relationships of Statins Therapy and Hyperlipidemia with the Incidence, Rupture, Post-repair Mortality and All-cause Mortality of Abdominal Aortic Aneurysm and Cerebral Aneurysm: A Meta-analysis and Systematic Review.
    J Cardiovasc Pharmacol. 2019 Jan 25. doi: 10.1097/FJC.0000000000000653.
    PubMed     Text format     Abstract available

    June 2018

  2. CaMKII Activation Promotes Cardiac Electrical Remodeling and Increases the Susceptibility to Arrhythmia Induction in High-fat Diet-Fed Mice With Hyperlipidemia Conditions: Erratum.
    J Cardiovasc Pharmacol. 2018;71:387.
    PubMed     Text format    

    March 2018
  3. BISGAIER CL, Oniciu DC, Srivastava RAK
    Comparative Evaluation of Gemcabene and PPAR Ligands in Transcriptional Assays of Peroxisome Proliferator-Activated Receptors: Implication for the Treatment of Hyperlipidemia and Cardiovascular Disease.
    J Cardiovasc Pharmacol. 2018 Mar 21. doi: 10.1097/FJC.0000000000000580.
    PubMed     Text format     Abstract available

    August 2017
  4. JOHNSTON TP, Korolenko TA, Sahebkar A
    The P-407-Induced Mouse Model of Dose-Controlled Hyperlipidemia and Atherosclerosis: Twenty-five Years Later.
    J Cardiovasc Pharmacol. 2017 Aug 4. doi: 10.1097/FJC.0000000000000522.
    PubMed     Text format     Abstract available

    July 2017
  5. ZHONG P, Quan D, Huang Y, Huang H, et al
    CaMKII activation promotes cardiac electrical remodeling and increases the susceptibility to arrhythmia induction in high fat diet-fed mice with hyperlipidemia conditions.
    J Cardiovasc Pharmacol. 2017 Jul 4. doi: 10.1097/FJC.0000000000000512.
    PubMed     Text format     Abstract available

    February 2016
    Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition--The Dream of Translational Medicine.
    J Cardiovasc Pharmacol. 2016;67:191-2.
    PubMed     Text format    

Thank you for your interest in scientific medicine.

AMEDEO Hyperlipoproteinemias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.